Targeting Olig2 co-regulators for malignant glioma therapy

被引：0
|
作者：
Kupp, Robert [1 ]
Lo Cascio, Costanza [1 ]
Rauf, Femina [2 ]
Meijer, Dimphna [3 ]
Stiles, Charles D. [3 ]
Sanai, Nader [1 ]
LaBaer, Joshua [2 ]
Mehta, Shwetal V. [1 ]
机构：
[1] Barrow Neurol Inst, Phoenix, AZ 85013 USA
[2] Arizona State Univ, Tempe, AZ USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.BRAIN15-B20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B20
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evolution of OLIG2 expression during radio(chemo)therapy has a prognostic value in glioblastoma.
    Bouchart, C.
    Trepant, A. L.
    Hein, M.
    Van Gestel, D.
    Salmon, I.
    Demetter, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1280 - S1281
  • [32] PRELIMINARY TRIAL OF SPECIFIC TARGETING THERAPY AGAINST MALIGNANT GLIOMA
    NITTA, T
    SATO, K
    YAGITA, H
    OKUMURA, K
    ISHII, S
    LANCET, 1990, 335 (8686): : 368 - 371
  • [33] Chronic D609 treatment interferes with cell cycle and targets the expression of Olig2 in Glioma Stem like Cells
    Kalluri, Haviryaji S. G.
    Kuo, John S.
    Dempsey, Robert J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 814 : 81 - 86
  • [34] The MicroRNA miR-17 modulates regulatory T cell activity by targeting Foxp3 Co-regulators
    Wu, C-Y
    Wu, R-C
    Yeh, K-W
    Huang, J-L
    Yang, H-Y
    ALLERGY, 2016, 71 : 82 - 82
  • [35] Future approaches for the therapy of malignant glioma: targeting genes mediating invasion
    Emdad, Luni
    Dent, Paul
    Sarkar, Devanand
    Fisher, Paul B.
    FUTURE ONCOLOGY, 2012, 8 (04) : 343 - 346
  • [36] Clinical results of specific targeting therapy against patients with malignant glioma
    Hishii, M
    Nitta, T
    Ebato, M
    Okumura, K
    Sato, K
    BRAIN TUMOR: RESEARCH AND THERAPY, 1996, : 363 - 370
  • [37] MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor
    Yang, Huang-Yu
    Barbi, Joseph
    Wu, Chao-Yi
    Zheng, Ying
    Vignali, Paolo D. A.
    Wu, Xingmei
    Tao, Jin-Hui
    Park, Benjamin V.
    Bandara, Shashika
    Novack, Lewis
    Ni, Xuhao
    Yang, Xiaoping
    Chang, Kwang-Yu
    Wu, Ren-Chin
    Zhang, Junran
    Yang, Chih-Wei
    Pardoll, Drew M.
    Li, Huabin
    Pan, Fan
    IMMUNITY, 2016, 45 (01) : 83 - 93
  • [38] Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate
    Schaefer, Thorsten
    Mittal, Nitish
    Wang, Hui
    Ataman, Meric
    Candido, Silvia
    Lotscher, Jonas
    Velychko, Sergiy
    Tintignac, Lionel
    Bock, Thomas
    Borsch, Anastasiya
    Bassler, Jochen
    Rao, Tata Nageswara
    Zmajkovic, Jakub
    Roffeis, Sarah
    Loliger, Jordan
    Jacob, Francis
    Dumlin, Alain
    Schurch, Christoph
    Schmidt, Alexander
    Skoda, Radek C.
    Wymann, Matthias P.
    Hess, Christoph
    Schoeler, Hans R.
    Zaehres, Holm
    Hurt, Ed
    Zavolan, Mihaela
    Lengerke, Claudia
    CELL REPORTS, 2024, 43 (10):
  • [39] Targeting FGL2 in glioma immunosuppression and malignant progression
    Ma, Xiaoyu
    Zhu, Hongtao
    Cheng, Lidong
    Chen, Xin
    Shu, Kai
    Zhang, Suojun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway (vol 16, pg 950, 2016)
    Singh, Shiv K.
    Fiorelli, Roberto
    Kupp, Robert
    Rajan, Sindhu
    Szeto, Emily
    Lo Cascio, Costanza
    Maire, Cecile L.
    Sun, Yu
    Alberta, John A.
    Eschbacher, Jennifer M.
    Ligon, Keith L.
    Berens, Michael E.
    Sanai, Nader
    Mehta, Shwetal
    CELL REPORTS, 2017, 19 (11): : 2410 - 2412
12345